Beta Bionics partners with Senseonics to integrate iLet bionic pancreas with Eversense 365 CGM

Bitget2026/09/22 11:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Beta Bionics entered a partnership with Senseonics to integrate iLet Bionic Pancreas with the Eversense 365 continuous glucose monitor.
Commercial launch of the integrated iLet-Eversense 365 system is expected in Q4 2026.
The companies also committed to integrate Beta Bionics’ mint automated insulin delivery system with Eversense 365 at a later date.
Beta Bionics expects iLet to support the widest range of CGM options among automated insulin delivery systems once the integration launches.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609220730PRIMZONEFULLFEED9830868) on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Beta Bionics partners with Senseonics to integrate iLet bionic pancreas with Eversense 365 CGM

You may also like

Crypto prices